259 related articles for article (PubMed ID: 10845297)
1. Neonatal induction of tolerance to skeletal tissue allografts without immunosuppression.
Butler PE; Lee WP; van de Water AP; Randolph MA
Plast Reconstr Surg; 2000 Jun; 105(7):2424-30; discussion 2431-2. PubMed ID: 10845297
[TBL] [Abstract][Full Text] [Related]
2. Vascularized bone grafts within composite tissue allotransplants can autocreate tolerance through mixed chimerism with partial myeloablative conditioning: an experimental study in rats.
Huang WC; Lin JY; Wallace CG; Chuang WY; Wei FC; Liao SK
Plast Reconstr Surg; 2010 Apr; 125(4):1095-1103. PubMed ID: 20072086
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
4. Prolongation of skin allograft survival after neonatal injection of donor bone marrow and epidermal cells.
Petit F; Minns AB; Nazzal JA; Hettiaratchy SP; Lantieri LA; Randolph MA; Lee WP
Plast Reconstr Surg; 2004 Jan; 113(1):270-6. PubMed ID: 14707646
[TBL] [Abstract][Full Text] [Related]
5. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
J Surg Res; 2012 Nov; 178(1):487-93. PubMed ID: 22484382
[TBL] [Abstract][Full Text] [Related]
6. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
7. Donor modification leads to prolonged survival of limb allografts.
Lee WP; Butler PE; Randolph MA; Yaremchuk MJ
Plast Reconstr Surg; 2001 Oct; 108(5):1235-41. PubMed ID: 11604625
[TBL] [Abstract][Full Text] [Related]
8. Effect of the vascularized bone components on the survival of vascularized composite allografts.
Chen J; Zhang D; Zhang T; Chen C; Song Y; Liu S; Su Y; Guo S
J Surg Res; 2018 Apr; 224():132-138. PubMed ID: 29506828
[TBL] [Abstract][Full Text] [Related]
9. Tolerance induction permits the development of graft-versus-host disease: donor-mediated attack following small bowel transplantation in mixed chimeras.
Morrissey NJ; Blom D; Ryan CK; Fisher T; Bronsther O; Orloff MS
Transpl Immunol; 1999 Mar; 7(1):19-25. PubMed ID: 10375074
[TBL] [Abstract][Full Text] [Related]
10. Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts.
Sakamoto T; Ye Q; Lu L; Demetris AJ; Starzl TE; Murase N
Transplantation; 1999 Mar; 67(6):833-40. PubMed ID: 10199731
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
12. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
Goss JA; Nakafusa Y; Yu S; Flye MW
Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
[TBL] [Abstract][Full Text] [Related]
14. Cellular mechanisms of alloimmune non-responsiveness in tolerant mixed lymphocyte chimeras induced by vascularized bone marrow transplants.
Llull R; Ramsamooj R; Black KS; Hewitt CW
Transpl Int; 1994; 7 Suppl 1():S453-6. PubMed ID: 11271279
[TBL] [Abstract][Full Text] [Related]
15. Skin allograft survival following intrathymic injection of donor bone marrow.
Cober SR; Randolph MA; Lee WP
J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
[TBL] [Abstract][Full Text] [Related]
16. [Adenovirus-mediated CTLA4 immunoglobulin based conditioning for non-myeloablative allogeneic hematopoietic cell transplantation to induce tolerance to hind limb allografts in rats].
Pan H; Wang L; Zhang XD; Mai HX; Liu D; Liu Y; Guo SZ
Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(12):937-40. PubMed ID: 19781252
[TBL] [Abstract][Full Text] [Related]
17. Intraosseus transplantation of donor-derived hematopoietic stem and progenitor cells induces donor-specific chimerism and extends composite tissue allograft survival.
Siemionow M; Zielinski M; Ozmen S; Izycki D
Transplant Proc; 2005 Jun; 37(5):2303-8. PubMed ID: 15964405
[TBL] [Abstract][Full Text] [Related]
18. The effect of bone marrow transplantation on survival of allogeneic pancreatic islets with short-term tacrolimus conditioning in rats.
Girman P; Kríz J; Dovolilová E; Cíhalová E; Saudek F
Ann Transplant; 2001; 6(2):43-5. PubMed ID: 11803619
[TBL] [Abstract][Full Text] [Related]
19. Donor bone marrow in laryngeal transplantation: results of a rat study.
Khariwala SS; Dan O; Lorenz RR; Klimczak A; Siemionow M; Strome M
Am J Otolaryngol; 2008; 29(4):242-9. PubMed ID: 18598835
[TBL] [Abstract][Full Text] [Related]
20. Vascularized bone marrow transplantation: A new surgical approach using isolated femoral bone/bone marrow.
Suzuki H; Patel N; Matthews M; DelRossi AJ; Doolin EJ; Hewitt CW
J Surg Res; 2000 Apr; 89(2):176-83. PubMed ID: 10729247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
